FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2022
Back to search
Official data from USPTO
IMMUNIC THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/29/2022
Trademark type
Combined
Nice classes
5, 42
Filing date
02/17/2021
Registration date
03/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/01/2022
Last transaction
03/01/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
HOFFMAN, DAVID AARON
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "IMMUNIC THERAPEUTICS" to the right of a design comprising various geometics shapes. The wording "IMMUNIC" is shown in the color blue, and "THERAPEUTICS" in grey. The geometric design is shown in various shades of blue. The mark is presented on a white background.
Holders and representatives
Holders
Immunic AG
Representatives
Adam D. Mandell Millen, White, Zelano & Branigan, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of chronic inflammatory diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Class 42
Pharmaceutical research and development; Medical and pharmacological research services; Research relating to biotechnology; Development of pharmaceutical preparations and medicines; Clinical research in the field of immunology; Consultancy in the field of pharmaceutical research
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2022
FIMP
FINAL DISPOSITION PROCESSED
08/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/14/2021
PUBO
PUBLISHED FOR OPPOSITION
12/14/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/13/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/05/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/04/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/04/2021
RFNT
REFUSAL PROCESSED BY IB
10/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/30/2021
RFRR
REFUSAL PROCESSED BY MPU
09/30/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/15/2021
CNRT
NON-FINAL ACTION WRITTEN
09/14/2021
DOCK
ASSIGNED TO EXAMINER
09/13/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/01/2021
Continuous trademark protection
Get notified about every new filing that threatens IMMUNIC THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.